From SBA 7(a) loans to earnouts and equity rollovers — a practical guide to deal structures for DMEPOS and durable medical equipment businesses in the $1M–$5M revenue range.
Acquiring or selling a medical equipment supplier involves deal structures shaped by the industry's unique mix of recurring rental revenue, Medicare/Medicaid reimbursement exposure, regulatory accreditation requirements, and supplier contract transferability. Unlike many lower middle market businesses, DMEPOS and DME acquisitions carry post-close regulatory risk — including reimbursement audits, accreditation continuity, and payer contract approvals — that meaningfully influences how purchase price is allocated and how risk is shared between buyer and seller. The most common structures in this space combine SBA 7(a) debt financing with seller notes or earnouts to bridge valuation gaps created by reimbursement uncertainty, while equity rollovers are increasingly used to retain seller involvement through regulatory transitions. Understanding which structure best fits your transaction depends on the quality of recurring revenue, the cleanliness of billing compliance history, the transferability of key supplier agreements, and the degree of owner dependency in the business.
Find Medical Equipment Supplier Businesses For SaleSBA 7(a) Loan with Seller Note
The most common structure for lower middle market DME and DMEPOS acquisitions. The buyer funds the majority of the purchase price through an SBA 7(a) loan — typically covering 70–80% of the deal — with a 10–20% buyer equity injection and a seller note of 5–10% to bridge any valuation gap. The seller note is often subordinated to the SBA loan and structured as a standby note during the initial loan period. This structure is particularly well-suited for Medicare-accredited DME businesses with clean billing histories and diversified payer mixes.
Pros
Cons
Best for: Owner-operated DMEPOS businesses with $300K–$700K EBITDA, clean Medicare billing compliance, active accreditation, and diversified referral relationships — particularly where the seller is motivated by a clean exit and willing to hold a small note to support transition.
Asset Purchase with Earnout
The buyer acquires specified business assets — including inventory, equipment, supplier contracts, customer lists, and accreditations — rather than the legal entity. A portion of the purchase price is deferred as an earnout tied to post-close performance metrics such as retention of key supplier distribution agreements, Medicare/Medicaid reimbursement approval continuity, or recurring rental revenue thresholds over 12–24 months. This structure is common when there is meaningful uncertainty around regulatory continuity or the transferability of exclusive distribution agreements.
Pros
Cons
Best for: Transactions where the business has meaningful Medicare/Medicaid revenue but carries some billing compliance history concerns, pending supplier contract renewals, or where the seller holds key physician or hospital referral relationships that require active transition support.
Equity Rollover with Partial Seller Retain
The seller retains a minority equity stake — typically 10–20% — in the acquired entity alongside a private equity buyer or strategic acquirer. The seller receives a majority cash payout at close while remaining an equity participant in the business going forward. This structure is most common in platform acquisitions or roll-up strategies where the seller's ongoing involvement is critical to regulatory continuity, physician referral relationship retention, or supplier agreement management during a defined transition period.
Pros
Cons
Best for: Medical equipment suppliers being acquired by private equity-backed healthcare platforms or strategic regional distributors executing roll-up strategies, particularly where the seller's physician relationships, DMEPOS accreditation knowledge, or exclusive supplier agreements are central to near-term business continuity.
SBA-Financed Acquisition of a DMEPOS Business with Clean Billing History
$2,100,000
SBA 7(a) loan: $1,470,000 (70%) | Buyer equity injection: $420,000 (20%) | Seller note: $210,000 (10%)
SBA loan structured over 10 years at prevailing SBA rates; seller note on 24-month standby per SBA requirements, then amortized over 3 years at 6% interest. Business generates $350,000 EBITDA on $2.1M revenue, implying a 6x multiple reflecting strong recurring rental revenue (60% of total), active DMEPOS accreditation, and no open Medicare audit exposure. Seller note subordinated to SBA lender; seller provides 12-month transition support and non-solicitation covering physician and hospital referral sources.
Asset Purchase with Earnout — Supplier Contract Transferability Risk
$1,750,000 (up to $2,050,000 with earnout)
Cash at close: $1,487,500 (85% of base price) | Earnout: Up to $300,000 over 24 months tied to retention of two exclusive distribution agreements and Medicare revenue exceeding $850,000 annually post-close
Buyer acquires all tangible assets, customer lists, and assignable contracts; excludes entity-level liabilities. Earnout measured at 12 and 24 months post-close; each milestone pays $150,000 upon achieving defined revenue and contract thresholds. Seller re-enrolls Medicare provider number under buyer's new entity within 90 days of close with cooperation obligations. Seller funded primarily through buyer equity and conventional bank debt given asset purchase structure outside SBA eligibility due to real estate exclusion.
Equity Rollover — PE Platform Add-On Acquisition
$4,500,000
Cash at close to seller: $3,825,000 (85%) | Equity rollover at close: $675,000 equivalent to 15% minority stake in recapitalized entity
Private equity-backed regional DME platform acquires 85% of seller's DMEPOS business; seller retains 15% equity stake with standard minority protections, drag-along rights, and a put option at a defined EBITDA multiple exercisable after 36 months. Seller remains as non-executive advisor for 24 months to manage physician referral transitions and supplier relationship continuity. Platform financing includes senior debt at 3x EBITDA; seller's rollover equity valued at same entry multiple as PE platform acquisition. Total enterprise value of $4.5M reflects 5.5x EBITDA on $820,000 adjusted EBITDA with premium for exclusive regional distribution rights.
Find Medical Equipment Supplier Businesses For Sale
Pre-screened targets ready for your deal structure — free to join.
The most common structure is an SBA 7(a) loan covering 70–80% of the purchase price, combined with a 10–20% buyer equity injection and a 5–10% seller note. This structure works well for Medicare-accredited medical equipment suppliers with clean billing histories and $300K–$700K in EBITDA. SBA financing is attractive because it offers 10-year amortization at competitive rates, making debt service manageable relative to the business's cash flow — particularly important in DME businesses where reimbursement rate variability can affect EBITDA year over year.
Medicare and Medicaid revenue is both a value driver and a source of deal structure complexity. Buyers pay premium multiples for businesses with stable, diversified Medicare reimbursement — but that same revenue creates post-close risk around CMS billing audits, reimbursement rate changes, and re-enrollment timelines when the business transfers. As a result, buyers often propose earnout provisions tied to maintaining Medicare revenue thresholds post-close, or structure asset purchases that exclude pre-close billing liabilities. Sellers should conduct an internal billing compliance review before going to market to reduce buyer concern and minimize the risk of earnout or escrow provisions.
Yes — earnouts tied to supplier and distribution agreement retention are common in DMEPOS acquisitions where the business holds exclusive or preferred distribution rights with nationally recognized medical brands. The earnout is typically paid in tranches at 12 and 24 months post-close, contingent on confirming that key contracts have been successfully assigned to the buyer and remain in good standing. Buyers should ensure the earnout metrics are objectively measurable and not subject to third-party consent risk outside the seller's control, while sellers should negotiate for earnout protections if a supplier declines to transfer a contract despite good-faith efforts.
Equity rollovers — where the seller retains a 10–20% minority stake post-close — are most common when a private equity-backed platform or strategic acquirer is buying the business as part of a roll-up strategy. The rollover serves two purposes: it retains the seller's institutional knowledge and referral relationships during the regulatory transition period, and it signals seller confidence in the business's future performance. For sellers, the rollover provides upside participation if the acquirer grows the platform and exits at a higher multiple. It is less suitable for retiring owners seeking full liquidity at close.
Inventory and capital equipment are typically valued through a combination of cost-basis aging analysis and fair market valuation, often conducted by a third-party appraiser as part of due diligence. Buyers focus heavily on inventory obsolescence risk — particularly for medical devices with short technology cycles — and will negotiate purchase price adjustments or closing-date inventory verification provisions. A common structure includes a net working capital peg that defines an agreed inventory value at close, with dollar-for-dollar adjustments if the final count falls short. Sellers should prepare a detailed inventory aging report with write-down analysis before entering exclusivity to avoid last-minute closing surprises.
Seller financing in the form of a subordinated seller note is common, particularly in SBA-structured transactions where the lender requires the seller to hold 5–10% of the purchase price as a standby note. Typical terms include a 24-month standby period during which no payments are made, followed by 3–5 year amortization at 5–7% interest. Seller notes serve as a confidence signal to SBA lenders and help bridge valuation gaps, especially in businesses where a portion of value is tied to relationships or accreditations that take time to confirm post-close. Sellers should expect SBA lenders to require the note to be fully subordinated to the senior loan throughout its term.
More Medical Equipment Supplier Guides
More Deal Structure Guides
Find the right target, structure the deal, and close with confidence.
Create your free accountNo credit card required
For Buyers
For Sellers